Oral Ibuprofen Versus Placebo in Treatment of Patent Ductus Arteriosus (PDA)in Preterm Infants

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2021
The management options of Patent Ductus Arteriosus are still controversial and differ between centers. Recently, conservative management has been gaining interest as the evidence of benefit from medical treatment in terms of mortality and morbidity is lacking. This study will compare oral ibuprofen (the standard treatment) with the conservative treatment, in terms of ductal closure and morbidity and mortality at discharge in preterm neonates less than 34 weeks.
Epistemonikos ID: 766f6eb7a0492ddfc82d197de58cebbb5cb3d8ed
First added on: May 13, 2024